Organoclick AB (ORGC) — Cash Flow-to-Debt Ratio
Organoclick AB (ORGC) has a Cash Flow-to-Debt Ratio of 0.00x as of March 2026, meaning its operating cash flow of Skr-435.00K could theoretically repay 0% of its total liabilities (Skr128.92 Million) in one year. Check Organoclick AB investment reinvestment rate to assess the company's total reinvestment commitment from operating cash flow.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Organoclick AB Cash Flow-to-Debt Ratio (2012–2025)
Historical debt coverage capacity for Organoclick AB across 14 annual periods. Also explore how large is Organoclick AB's balance sheet for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Organoclick AB (2012–2025)
Year-by-year debt coverage analysis for Organoclick AB. For market capitalisation and broader financial context, see ORGC market cap.
| Year | CF-to-Debt Ratio | Operating CF (SEK) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.07x | Skr-8.29 Million | Skr114.81 Million | ▼ -278.7% |
| 2024 | 0.04x | Skr3.60 Million | Skr89.15 Million | ▲ +637.9% |
| 2023 | 0.01x | Skr533.00K | Skr97.34 Million | ▲ +102.5% |
| 2022 | -0.22x | Skr-21.22 Million | Skr95.30 Million | ▲ +52.3% |
| 2021 | -0.47x | Skr-37.69 Million | Skr80.66 Million | ▼ -696.6% |
| 2020 | 0.08x | Skr5.47 Million | Skr69.86 Million | ▲ +150.3% |
| 2019 | -0.16x | Skr-11.01 Million | Skr70.73 Million | ▲ +56.7% |
| 2018 | -0.36x | Skr-19.16 Million | Skr53.30 Million | ▲ +17.6% |
| 2017 | -0.44x | Skr-20.72 Million | Skr47.49 Million | ▼ -18.7% |
| 2016 | -0.37x | Skr-15.55 Million | Skr42.31 Million | ▲ +65.6% |
| 2015 | -1.07x | Skr-24.42 Million | Skr22.83 Million | ▼ -11.2% |
| 2014 | -0.96x | Skr-17.28 Million | Skr17.96 Million | ▼ -2767.1% |
| 2013 | 0.04x | Skr313.54K | Skr8.69 Million | ▲ +101.4% |
| 2012 | -2.67x | Skr-18.47 Million | Skr6.92 Million | — |